Vitamin D: Status, supplementation and immunomodulation

Current Nutrition and Food Science

Volumn 2, Issue 4, 2006, Pages 315-336

  Barnes, Maria S ^a   Robson, Paula J ^a   Bonham, Maxine P ^a   Strain, J J ^a   Wallace, Julie M W ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Autoimmune disease; Latitude; Multiple sclerosis; Vitamin D; Vitamin D status; Vitamin D supplementation

Indexed keywords

7 DEHYDROCHOLESTEROL; CALCIFEDIOL; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D; VITAMIN D RECEPTOR;

ADOLESCENCE; ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BIOSYNTHESIS; CALCIUM INTAKE; CARDIOTOXICITY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DIETARY REFERENCE INTAKE; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYDROXYLATION; HYPERCALCEMIA; HYPERCALCIURIA; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; REVIEW; RICKETS; RISK FACTOR; SEASONAL VARIATION; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN D METABOLISM; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ANIMALIA;

EID: 33750683939     PISSN: 15734013     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340106778699403     Document Type: Review

References (240)

1. Jones G, Strugnell S, DeLuca H. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78: 1193-1231.
2. Basu T, Dickerson J Ed, In: Vitamins in human health and disease. Wallingford, Oxon, UK CAB International 1996.
3. In: Marks J Ed, A guide to the vitamins: their role in health and disease. England: Medical and Technical Publishing Co Ltd 1975.
4. COMA. Report of the Subgroup on Bone Health, Working Group on the Nutritional Status of the population, Committee on Aspects of Food and Nutrition Policy. Nutrition and bone health: with particular reference to calcium and vitamin D. London: HMSO 1998.
5. Holick M. Evolution and function of vitamin D. Recent Results Cancer Res 2003; 164: 3-28.
6. Holick M. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61: 638-645.
7. Holick M. Vitamin D deficiency: what a pain it is. Mayo Clin Proc 2003; 78 (12): 1457-1459.
8. Holick M. Vitamin D: A millenium perspective. J Cell Biochem 2003; 88: 296-307.
9. 3. Biochemistry 1968; 7: 3317-3322.
10. Haddad J, Matsuoka L, Hollis B, Hu Y, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91 (6): 2552-2555.
11. DeLuca H, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998; 56: S4-S9.
12. 3. In: Norman A W, Bouillon R, Thomasset M Ed, Vitamin D Endocrine System: Structural, biological, genetic and clinical aspects 2000; 159-162.
13. 3-la-hydroxylase. J Clin Endocrinol Metab 2001; 86 (2): 888-894.
14. Hewison M. Vitamin D and the immune system. J. Endocrinol 1992; 132: 173-175.
15. van Leeuwen JP, van den Bend GJ, van Driel M, Buurman CJ, Pols HA. 24,25-Dihydroxyvitamin D(3) and bone metabolism. Steroids 2001; 66 (3-5): 375-80.
16. Reports on public health and medical subjects No. 120. Recommended Intakes of Nutrients for the United Kingdom. London: HMSO 1969.
17. Reports on health and social subjects No. 15. Recommended Daily Amounts of Food Energy and Nutrients for Groups of People in the United Kingdom. London: HMSO 1979.
18. Smith R, Dent C. Vitamin D requirements in adults. Clinical and metabolic studies on seven patients with nutritional osteomalacia. Bib] Nutr Dicta 1969; 13:44-45.
19. Vieth R, Fraser D. Vitamin D insufficiency: no recommended dietary allowance for this nutrient. Can Med Assoc J 2002; 166 (12): 1541-1542.
20. Park E. The therapy of rickets. JAMA 1940; 115: 370-379.
21. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for Calcium, Magnesium, Phosphorus, Vitamin D and Fluoride. Washington, DC: National Academy Press 1997.
22. Dawodu A, Agarwal M, Hossain M, Kochiyl J, Zayed R. Hypovitaminosis D and vitamin D deficiency in exclusively breast-feeding infants and their mothers in summer: A justification for vitamin D supplementation of breast-feeding infants. J Pediatrics 2003; 142: 169-173.
23. Heaney R. Vitamin D: How much do we need, and how much is too much? Osteoporos Int 2000; 11: 553-555.
24. Calvo, M, Whiting S, Barton C. Vitamin D intake: a global perspective of current status. J Nutr 2005; 135: 310-316.
25. Moore C, Murphy M, Keast D, Holick M. Vitamin D intake in the United States. J Am Diet Assoc 2004; 104: 980-983.
26. Hill T, O'Brien M, Cashman K, Flynn A, Kiely M. Vitamin D intakes in 18-64 year old Irish adults. Eur J Clin Nutr 2004; 5: 1-9.
27. National Academy of Sciences. Fortification Basics Maize Flour/Meal. Roche/USAID. 1997.
28. Blum M. Micromitrients and Health - Mandatory food enrichment. Nutriview 2000; (Special Issue 2000).
29. Department of Health. The fortification of yellow fats with vitamins A and D. London: HMSO 1991.
30. Holick M, Shao Q, Liu W, Chen T. The vitamin D content of fortified milk and infant formula. N Engl J Med 1992; 326 (18): 1178-1181.
31. Holick M. McCollum Award Lecture. Vitamin D: New horizons for the 21st century. Am J Clin Nutr 1994; 60 (4): 619-630.
32. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000; 247: 260-268.
33. 3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67 (2): 373-378.
34. 3. Ann Rev Nutr 1988; 8: 325-399.
35. Webb A, Pilbean C, Hanafin N, Holick M. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990; 51: 1075-1081.
36. Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003; 62: 813-821.
37. Sherman S, Hollis B, Tobin J. Vitamin D status and related parameters in a healthy population: The effects of age, sex, and season. J Clin Endocrinol Metab 1990; 71: 405-413.
38. Delvin E, Imbach A, Copti M. Vitamin D nutritional status and related biochemical indices in an autonomous elderly population. Am J Clin Nutr 1988; 48: 373-378.
39. Haddad J, Chyu K. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol 1971; 33: 992-995.
40. Jones G. Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography. Clin Chem 1978; 24: 287-298.
41. 125I-labeled tracer. Clin Chem 1993; 39: 529-533.
42. Armbruster F, Friedl S, Karmatschek M, Heckl-Osstreicher B, Reichel H, Woloszczuk W. Development of a novel ELISA for 1,25-dihydroxyvitamin D. Clin Lab 2000; 46: 165-166.
43. Clive D, Sudhaker D, Giacherio D, Gupta M, Schreiber J, Sackrison J, et al. Analytical and clinical validation of a radioimmunoassay for the measurement of 1,25 dihydroxyvitamin D. Clin Biochem 2002; 35: 517-521.
44. Chapuy M, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-443.
45. Dawson-Hughes B, Harris S, Dallal G. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997; 65: 67-71.
46. Holick M. Redefining vitamin D insufficiency. Lancet 1998; 351: 805-806.
47. Thomas M, Lloyd-Jones D, Thadhani R, et al. Hypovitaminosis in medical inpatients. N Eng J Med 1998; 338: 777-783.
48. Bates C, Carter G, Mishra G, O'Shea D, Jones J, Prentice A. In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int 2003; 4: 152-159.
49. Kudlacek S, Scheider B, Peterlik M, et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 2003; 33: 323-331.
50. Hollis B. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322.
51. Lips P, Chapuy M, Dawson-Hughes B, Pols H, Holick M. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999; 9: 394-397.
52. 3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004; 89-90: 575-579.
53. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Ster Biochem Mol Biol 2004; 89: 611-614.
54. Parfitt A, Gallagher J, Heaney R, Johnston C, Neer R, Whedon G. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982; 36: 1014-1031.
55. Hutchison F, Bell N. Osteomalacia and rickets. Semin Nephrol 1992; 12: 127-145.
56. Gloth F, Gundberg C, Hollis B, Haddad J, Tobin J. Vitamin D deficiency in homebound elderly persons. J Am Med Assoc 1995; 274: 1683-1686.
57. Wortsman J, Matsuoka L, Chen T, Lu Z, Holick M. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
58. Fine R. Sunscreens and cutaneous vitamin D synthesis. Intern J Dermatol 1988; 27: 300-301.
59. Odes H, Fraser G, Krugliak P, Lamprecht S, Shany S. Effect of cimetidine on hepatic vitamin D metabolism in humans. Digestion 1990; 46 (2): 61-64.
60. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856.
61. 3 intake exceeding the lowest observed adverse effect level (LOAEL). Am J Clin Nutr 2001; 73: 288-294.
62. Gertner J, Domenech M. 25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. Clin Pathol 1977; 30: 144-150.
63. Mawer E, Hann J, Berry J. Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci 1985; 68: 135-141.
64. Fuleihan G, Nabulsi M, Choucair M, et al. Hypovitaminosis D in healthy schoolchildren. Pediatrics 2001; 107 (4): 53-60.
65. Agarwal K, Mughal M, Upadhyay P, Berry J, Mawer E, Puliyel J. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Dehli, India. Arch Dis Childhood 2002; 87: 111-113.
66. Ala-Houhala M, Parviainen M, Pyykko K, Visakorpi J. Serum 25-hydroxyvitamin D levels in Finnish children aged 2 to 17 years. Acta Peadiatr Scand 1984; 73: 232-236.
67. Guillemant J, Cabrol S, Allemandou A, Peres G, Guillemant S. Vitamin D-dependent seasonal variation of PTH in growing male adolescents. Bone 1995; 17: 513-516.
68. Guillemant J, Taupin P, Le H, et al. Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 1999; 10: 222-225.
69. Lehtonen-Veromaa M, Mottonen T, Irjala K, et al. Vitamin D intake is low and hypovitaminosis D common in healthy 9 to 15 year old Finnish girls. Eur J Clin Nutr 1999; 53: 746-751.
70. 3 supplements. Osteoporos Int 2001; 12: 875-879.
71. Abrams SA, Griffin IJ, Hawthorne KM, Gunn SK, Gundberg CM, Carpenter TO. Relationships among vitamin D levels, parathyroid hormone, and calcium absorption in young adolescents. J Clin Endocrinol Metab 2005; 90 (10): 5576-81.
72. Andersen R, Molgaard C, Skovgaard L, et al. Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 2005; 59 (4): 533-41.
73. Lamberg-Allardt C, Ala-Houhala M, Ahola M, Parviainen M, Rasanen L, Visakorpi J. Vitamin D status of children and adolescents in Finland. Ann Nutr Metab 1986; 30: 267-272.
74. Tripp M, Herrmann N, Parcel G, Chamberlain R, Gritz E. Sun protection is fun! A skin cancer prevention program for preschools. J School Health 2000; 70 (10): 395-401.
75. Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann A, Sorensen O. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 2001; 86 (Suppl. 1): S97-S103.
76. Nakamura K, Nashimoto M, Matsuyama S, Yamamoto M. Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. Nutrition 2001; 17: 921-925.
77. Barger-Lux M, Heaney R. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002; 87 (11): 4952-4956.
78. Rucker D, Allan J, Fick G, Hanley D. Vitamin D insufficiency in a population of healthy Western Canadians. Canad Med Assoc J 2002; 166 (12): 1517-1524.
79. Tangpricha V, Pearce E, Chen T, Holick M. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002; 112: 659-662.
80. Hamson C, Goh L, Sheldon P, Samanta A. Comparative study of bone mineral density, calcium, and vitamin D status in the Gujarati and white populations of Leicester. Postgrad Med J 2003; 79 (931): 279-283.
81. Arya V, Bhambri R, Godbole M, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 2004; 15: 56-61.
82. Better O, Shabtai M, Kedar S, et al. Increased incidence of nephrolithiasis in lifeguards in Israel. In: Massry SG, Ritz E, Jahrei G. Ed, Phosphate and minerals in health and disease. New York: Plenum Press 1980; 467-472.
83. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr 1999; 81: 133-137.
84. Chapuy M, Schott A, Garnero P, Hans D, Delmas P, Meunier P. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol. Metab 1996; 81 (3): 1129-1133.
85. Bettica, P, Bevilacqua M, Vago T, Norbiato G. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in Northern Italy for initial screening. Osteoporos Int 1999; 9: 226-229.
86. Semba R, Garrett E, Johnston B, Guralnik J, Fried L. Vitamin D deficiency among older women with and without disability. Am J Clin Nutr 2000; 72: 1529-1534.
87. Aguado P, del Campo M, Garces M, et al. Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 2000; 11: 739-744.
88. Sigurdsson G, Franzson L, Steingrimsdottir L, Sigvaldason H. The association between parathyroid hormone, vitamin D and bone mineral density in 70 year old Icelandic women. Osteoporos Int 2000; 11: 1031-1035.
89. Isaia G, Giorgino R, Rini G, Bevilacqua M, Maugeri D, Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 2003; 14: 577-582.
90. McKenna M, Freaney R, Meade A, Muldowney F. Hypovitaminosis D and elevated serum alkaline phosphatase in elderly Irish people. Am J Clin Nutr 1985; 41: 101-109.
91. Lips P, van Ginkel F, Jongen M, Rubertus F, van der Vijgh W, Netelenbos J. Determinants of vitamin D status in patients with hip fractures and in elderly control subjects. Am J Clin Nutr 1987; 46: 1005-1010.
92. Scharla S, Scheidt-Nave C, Leidig G, et al. Lower serum 25-dihydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes 1996; 104: 289-292.
93. Boonen S, Vanderschueren D, Cheng X, Verbeke G, Dequeker J, Geusens P, et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res 1997; 12: 2119-2126.
94. Bates C, Prentice A, Cole T, et al. Micronutrients: highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over. Br J Nutr 1999; 82: 7-15.
95. Melin A, Wilske J, Ringertz H, Saaf M. Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging 1999; 11: 200-207.
96. McNeill G, Vyvyan J, Peace H, et al. Predictors of micronutrient status in men and women over 75 years old living in the community. Br J Nutr 2002; 88: 555-561.
97. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001; 24: 1496.
98. Hirani V, Primatesta P. Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population survey. Age Aging 2005; 34 (5): 485-91.
99. Lehtonen-Veromaa M, Mottonen T, Nuotio I, Irjala K, Leino A, Viikari J. Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3 year prospective study. Am J Clin Nutr 2002; 76 (6): 1446-1453.
100. Heaney R, Barger-Lux M, Dowell S, Chen T, Holick M. Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 1997; 82 (12): 4111-4116.
101. Barger-Lux M, Heaney R, Dowell S, Chen T, Holick M. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998; 8: 222-230.
102. Davie M, Lawson D, Emberson C, Barnes J, Roberts G, Barnes N. Vitamin D from skin: contribution to vitamin D status compared with oral vitamin D in normal and anticonvulsant-treated subjects. Clin Sci 1982; 63: 461-472.
103. Heaney R, Davies F, Chen T, Holick M, Barger-Lux M. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-210.
104. Patel R, Collins D, Bullock S, Swaninathan R, Blake G, Fogelman I. The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study. Osteoporos Int 2001; 12: 319-325.
105. 2. Am J Clin Nutr 1998; 68 (4): 854-858.
106. Chel V, Ooms M, Popp-Snijders C. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 1998; 13: 1238-1242.
107. Muskiet F. Do we really need >/= 100mcg vitamin D and is it safe for all of us? Am J Clin Nutr 2001; 74: 862-867.
108. Barnes MS, Robson PJ, Bonham MP, Strain JJ, Wallace JM. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr 2006; 60: 727-733.
109. Brooke O, Brown I, Bone C. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J 1980; 1: 751-754.
110. Cockburn F, Belton N, Purvis R. Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J 1980; 5: 11-14.
111. Ala-Houhala M. 25(OH)D levels during breast-feeding with or without maternal or infantile supplementation of vitamin D. J Pediatr Gastroenterol Nutr 1985; 4: 220-226.
112. Delvin E, Salle L, Glorieux F, Adeleine P, David L. Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatrics 1986; 109: 328-334.
113. Mallet E, Gugi B, Brunelle P, Henocq A, Basuyau J, Lemeur H. Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet Gynaecol 1986; 68: 300-304.
114. Datta S, Alfaham M, Davies D. Vitamin D deficiency in pregnant women from a non-European ethnic minority population: an international study. Br J Obstet Gynaecol 2002; 109: 905-908.
115. Hollis B. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996; 58: 4-5.
116. Hollis B, Wagner C. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 2004; 79: 717-726.
117. Mahomed K, Gulmezoglu A. Vitamin D supplementation in pregnancy. Cochrane Database Syst Rev 2000; 2: CD000228.
118. van Der Klis F, Jonxis J, van Doormatal J, Sikkens P, Saleh A, Muskiet F. Changes in vitamin-D metabolites and parathyroid hormone in plasma following cholecalciferol administration to pre and postmenopausal women in the Netherlands in early spring and to postmenopausal women in Curacao. Br J Nutr 1996; 75: 637-646.
119. Dawson-Hughes B, Dallal G, Krall E, Harris S, Sokoll L, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991; 115 (7): 505-512.
120. Dawson-Hughes B, Harris S, Krall E, Dallal G, Falconer G, Green C. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995; 61: 1140-1145.
121. Panunzio M, Pisano A, Telesforo P, Tomaiuolo P. Diet can increase 25-hydroxyvitamin-D3 plasma levels in the elderly: a dietary intervention trial. Nutr Res 2003; 23: 1177-1181.
122. McAuley Y, Jones S, Lewis-Barned N, Manning P, Goulding A. Low vitamin D status is common among elderly Dunedin women. New Zealand Med J 1997; 110: 275-277.
123. Graafmans W, Lips P, Ooms M, van Leeuwen J, Pols H, Uitterlinden A. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Re 1997; 12: 1241-1245.
124. MacLennan W, Hamilton J. Vitamin D supplements and 25-hydroxy vitamin D concentrations in the elderly. Br Med J 1977; 2: 859-861.
125. Lips P, Graafmans W, Ooms M, Bezemer P, Bouter L. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 15: 400-406.
126. Sebert J, Garabedian M, Charuvenet M, Maamer M, Agbomson F, Brazier M. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents. Rev Rhum Engl 1995; 62: 288-294.
127. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-1642.
128. Dawson-Hughes B, Harris S, Krall E, Dallal G. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337 (10): 670-676.
129. 2 supplementation on calcium absorption in elderly women with vertebral fractures. Osteoporos Int 1996; 6: 284-290.
130. Sorva A, Risteli J, Risteli L, Valimaki M, Tilvis R. Effects of vitamin D and calcium on markers of bone metabolism in geriatric patients with low serum 25-hydroxyvitamin D levels. Calcif Tissue Int 1991; 49 (suppl): S88-89.
131. Honkanen R, Alhava E, Parviainen M, Talasniemi A, Monkkonen R. The necessity and safety of calcium and vitamin D in the elderly. J Am Geriatr Soc 1990; 38: 862-866.
132. Nordin B, Baker M, Horsman A, Peacock M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985; 42: 470-474.
133. Suda T, Ueno Y, Fujii K, Shinki T. Vitamin D and bone. J Cell Biochem 2003; 88 (2): 259-266.
134. Provvedini D, Tsoukas C, Deftos L, Manolagas S. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221: 1181-1183.
135. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983; 57: 1308-1310.
136. 3 receptor in the immune system. Arch Biochem Biophys 2000; 374 (2): 334-338.
137. Holick M. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79: 362-371.
138. 3. Proc Natl Acad Sci USA 1981; 78: 4990-4994.
139. 3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine mononuclear cell factor. J Clin Invest 1984; 73: 731-739.
140. Amento E. Vitamin D and the immune system. Steroid 1987; 49: 55-72.
141. D'Ambrosio D, Cippitelli M, Cocchiolo M, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101: 252-262.
142. 3 - a hormone with immunomodulatory properties. Z Rheumatol 2000; 59 (Suppl 1): 24-27.
143. Rigby W, Shen L, Ball E, Guyre P, Fanger M. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood 1984; 64: 1110-1115.
144. DeLuca H, Cantorna M. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579-2585.
145. Koeffler H, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca H. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 1984; 44: 5624-5628.
146. Rook G, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes. Immunol 1986; 57: 159-163.
147. 3 and their relation in alveolar macrophages. Proc Natl Acad Sci USA 1984; 81 (22): 7112-7116.
148. Goldman R. Introduction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 15-dihydroxyvitamin D3. Cancer Res 1984; 44: 11-19.
149. Cantorna M, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3 and the immune system. Am J Clin Nutr 2004; 80: 1717-1720.
150. Lemire J, Adams J, Kermani-Arab V, Bakke A, Sakai R, Jordan S. 1,25 dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134: 3032-3035.
151. Reichel H, Koeffler H, Tobler A, Norman A. 1a-25-dihydroyxvitamin D3 inhibits g-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1987; 84: 3385-3389.
152. 3 and the immune system. Proc Soc Exp Biol Med 1989; 191: 238-245.
153. Tsoukas C, Provvedini D, Manolagas S. 1,25-dihydroxyvitamin D3: A novel immunoregulatory hormone. Science 1984; 224: 1438-1440.
154. Rigby W, Denome S, Fanger M. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. J Clin Invest 1987; 79: 1659-1664.
155. Cantorna M, Hayes C, DeLuca H. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128: 68-72.
156. Brennan A, Katz D, Nunn J, Barker S, Hewison M. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite dihydroxycholecalciferol. J Immunol 1987; 61: 457-461.
157. Penna G, Adorini L. 1-alpha-25, dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405-2411.
158. 3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 6800-6805.
159. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552-572.
160. Wolfgram F. Similar geographical distribution of multiple sclerosis and cancer of the colon. Acta Neurol Scand 1975; 52: 294-302.
161. Templer D, Cappelletty G, Kauffman I. Schizophrenia and multiple sclerosis. Distribution in Italy. Br J Psych 1988; 153: 389-390.
162. Garland F, Garland C, Gorham E, Young J. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prevent Med 1990; 19: 614-622.
163. Garland C, Garland F, Shaw E, Comstock G, Helsing K, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 1: 1176-1178.
164. Hanchette C, Schwartz G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70: 2861-2869.
165. Schwartz G. Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiol 1992; 11: 244-254.
166. Ahonen M, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and pre-diagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Contr 2000; 11: 847-852.
167. Brunvand L, Quigstad E, Urdal P, Hang E. Vitamin D deficiency and fetal growth. Early Human Development 1996; 45: 27-33.
168. Hayes C, Cantorna M, DeLuca H. Vitamin D and multiple sclerosis. Proc Soc Exper Biol Med 1997; 216: 21-27.
169. van Amerongen B, Dijkstra C, Lips P, Polman C. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58: 1-15.
170. McGrath J. Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses 2001; 56 (3): 367-371.
171. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 7861-7864.
172. Ebers G, Sadovnick A. Association studies in multiple sclerosis. J Neuroimmunol 1994; 53: 117-122.
173. Coles A, Wing M, Compston D. Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapy. Mult Scler 1998; 4: 232-238.
174. Hafler D, Weiner H. MS: a CNS and systemic autoimmune disease. Immunol Today 1989; 10: 104-107.
175. In: Hallpike J, Adams C, Tourtellote W. Ed, Multiple Sclerosis: Pathology, Diagnosis and Management. London: Chapman and Hall 1983.
176. Bertolotto A, Capobianco M, Malucchi S, et al. Transforming growth factor b1 (TGFb1) mRNA level correlates with magnetic resonance imaging disease activity in Multiple Sclerosis patients. Neurosci Letters 1999; 263: 21-24.
177. Bertolotto A, Malucchi S, Capobianco M, et al. Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. J Interferon Cytokine Res 1999; 19: 575-581.
178. Clerici M, Saresella M, Trabattoni D, et al. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol 2001; 121: 88-101.
179. Killestein J, Den Drijver B, Van der Graaff W, Uitdehaag B, Polman C, Van Lier R. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease. Mult Scler 2001; 7: 145-150.
180. Clarke CR. Neurological disease: multiple sclerosis. In: Kumar P, Clark M Saunders, WB Ed, Clinical Medicine. Edinburgh, 1998; 1068-1070.
181. Allen C, Lueck C, editors. Diseases of the nervous system: multiple sclerosis. In: Haslett C, Chilvers ER. Ed, Davidson's Principles and Practice of Medicine. Edinburgh, Churchill Livingstone 1999; 983-986.
182. Goldberg P. Multiple Sclerosis, Vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 1: sunlight, dietary factors and epidemiology. Int J Environ Studies 1974; 6: 19-27.
183. Hutter C, Laing P. Multiple sclerosis: sunlight, diet, immunology and aetiology. Med Hypotheses 1996; 46: 67-74.
184. Kurtzke J. Geography in Multiple Sclerosis. J Neurol 1977; 215: 1-26.
185. Hernan M, Olek M, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurol 1999; 51: 1711-1718.
186. Ponsonby A, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicol 2002; 181 (182): 71-78.
187. Hayes C. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 2000; 59: 531-535.
188. Pozzilli C, Romano S, Cannoni S. Epidemiology and current treatment of multiple sclerosis in Europe today. J Rehab Res Devel 2002; 39 (2): 175-186.
189. Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 2005; 64: 608-618.
190. McGuigan C, McCarthy A, Quigley C, Bannan L, Hawkins S, Hutchison M. Latitudinal variation in the prevalence of multiple sclerosis in
191. McDonnell G, Hawkins S. An epidemiologic study of multiple sclerosis in Northern Ireland. J Neurol 1998; 50 (2): 423-428.
192. Embry A, Snowdon L, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48: 271-272.
193. Templer D, Trent N, Spencer D. Season of birth and multiple sclerosis. Acta Neurol Scand 1992; 85: 107-109.
194. Bharanidharan P. Monthly distribution of multiple sclerosis patients' births. Int J Biometeorol 1997; 40 (2): 117-118.
195. van der Mei I, Ponsonby A, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J 2003; 327 (316): 1-6.
196. Willer C, Dyment D, Sadovnick A, Rothwell P, Murray T, Ebers G. Timing of birth and risk of multiple sclerosis: population based study. Br Med J 2005; 330: 120-125.
197. 3 analog and a bisphoshonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone 2003; 32: 397-404.
198. 3 prevents the in vivo induction of murine experimental autoimmumune encephalomyelitis. J Clin Invest 1991; 87 (3): 1103-1107.
199. D3. J Neuroimmunol 1995; 61: 151-160.
200. Mattner F, Smiroldo S, Galbiati F, et al. Inhibition of Thl development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3. Eur J Immunol 2000; 30 (2): 498-508.
201. Cantorna M, Humpal-Winter J, DeLuca H. Dietary calcium is a major factor in 1,25 dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 1999; 129: 1966-1971.
202. Chaudhuri A, Behan PO. Multiple sclerosis: looking beyond autoimmunity. J R Soc Med 2005; 98 (7): 303-6.
203. Goldberg P, Fleming M, Picard E. Multiple sclerosis decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986; 21: 193-200.
204. Munger K, Zhang S, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-65.
205. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994; 44: 1687-1692.
206. Cosman F, Nieves J, Komar L, et al. Fracture history and bone loss in patients with MS. Neurology 1998; 51: 1161-1165.
207. Mahon B, Gordon S, Cruz J, Cosman F, Cantorna M. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134: 128-132.
208. Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 2005; 23: 309-313.
209. Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005; 11: 266-271.
210. Hughes M. Multiple sclerosis and pregnancy. Neurol Clin 2004; 22: 757-769.
211. Cantorna M, Mahon B, Bemiss C, Gordon S, Cruz J, Cosman F. Altered cytokine profile in patients with multiple sclerosis following vitamin D supplementation. Ann Nutr Metab 2001; 45 (suppl. 290).
212. O'Garra A, Murphy K. T-cell subsets in autoimmunity. Curr Opin Immumol 1993; 5: 880-886.
213. Voskuhl R, Martin R, Bergman C, Dalai M, Ruddle N, McFarland H. T helper 1 (Th 1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmun 1993; 15: 137-143.
214. Pedersen P, Michaelsen K, Molgaard C. Children with nutritional rickets referred to hospitals in Copenhagen during a 10-year period. Acta Paediatrica 2003; 92: 87-90.
215. Bloom E, Klein E, Shushan D, Feldman K. Variable presentations of rickets in children in the emergency department. Pediatric Emergency Care 2004; 20 (2): 126-130.
216. Vieth R. Vitamin D nutrition and its potential health benefits for bone, cancer and other conditions. J Nutr Environ Med 2001; 11: 275-291.
217. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90 (7): 4119-23.
218. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report 41. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London, HMSO 1997.
219. Danish Food Agency. Danskernes Kostvaner 1995 (The Danish Dietary Survey 1995). Copenhgen, Denmark, Danish Food Agency. 1996.
220. Deutsche Gesellschaft fur Ernahrung. Ernahrungsbericht 2000 (Nutrition Report 2000). Frankfurt am Main: Druckerei Heinrich 2000.
221. Volatier J. Enquete Individuelle et Nationale sur les consommations Alimentaires (Individual and National Study of Food Consumption). TEC et DOC Lavoisier, Paris 2000.
222. Hulsof K, Kistemaker C, Bouman M. De inname van energie en voedingsstoffen door Nederlandse bevolkings-groepen - Voedselconsumptiepeiling 1997-1998 (The intake of energy and nutrients in the Dutch population - Food Consumption Survey 1997-1998). Ziest, The Netherlands: TNO Report. 1998; V98-V105.
223. McCance and Widdowson's The Composition of Foods. Food Standards Agency. Cambridge, Royal Society of Chemistry, Sixth summary edition. 2002.
224. McKenna M. Differences in vitamin D status between countries in young adults and elderly. Am J Med 1992; 93: 69-77.
225. Zittermann A, Scheld K, Stehle P. Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur J Clin Nutr 1998; 52 (7): 501-506.
226. McKenna M, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 1998; 8 (2): S3-S6.
227. Malabanan A, Veronikis I; Holick M. Redefining vitamin D insufficiency. Lancet 1998; 351 (9105): 805-806.
228. Parfitt A. Osteomalacia and related disorders. In: Avioli L, Krane S, Ed, Metabolic Bone Disease. San Diego, California: Academic Press. 1998; 327-386.
229. Gallagher J, Kinyamu H, Fowler S, Dawson-Hughes B, Dalsky G, Sherman S. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 1998; 13: 475-482.
230. Nurmi I, Kaukonen JP, Luthje P, et al. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporos Int 2005; 16 (12): 2018-24.
231. 2 supplementation on serum 25(OH)D concentration is weak among peripubertal Finnish girls: a 3 year prospective study. Eur J Clin Nutr 2002; 56: 431-437.
232. Cooper L, Clifton-Bligh P, Nery M, et al. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 2003; 77: 1324-1329.
233. 3 sufficient early postmenopausal healthy women. Eur J Clin Nutr 2004; 58: 1420-1424.
234. Davies P. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985; 66: 301-306.
235. Lips P, Wiersinga A, van G. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988; 67: 644-650.
236. D. Am J Clin Nutr 1990; 52: 701-706.
237. Freaney R, McBrinn Y, McKenna M. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr 1993; 58: 187-191.
238. Ooms M, Roos J, Bezemer P, van der Vijgh W, Bouter L, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995; 80 (4): 1052-1058.
239. Stamp T, Haddad J, Twigg C. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1977; 1: 1341-1343.
240. 3 or 1,25-dihydroxycholecalciferol. Lancet 1980; 2: 612-615.